Ageless Pep Academy Clinical Education · Licensed Prescribers

PMID-34834147 – Peptide Regulation of Gene Expression Systematic Review

PMID-34834147 – Peptide Regulation of Gene Expression: A Systematic Review

Khavinson VKh, Linkova NS, Kolchina NV, Ilina AR, Petukhov MG. Peptide Regulation of Gene Expression: A Systematic Review. Molecules. 2021;26(22):7053.

Quick Reference

Property Value
PMID 34834147
DOI 10.3390/molecules26227053
Year 2021
Journal Molecules
Study Type Systematic Review
Evidence Level V — Single-group systematic review of predominantly preclinical data
Sample Review of published literature on ultrashort peptides (2-7 amino acids)
Peptide(s) Studied Vilon, Livagen, Cortagen, Cardiogen, Pancragen, Testagen, Crystagen, Chonluten, Cartalax, Prostamax, Pinealon, Epitalon

Key Findings

  • Ultrashort peptides (USPs) consisting of 2-7 amino acid residues act as signaling molecules that regulate gene expression and protein synthesis
  • Short peptides can penetrate cell membranes and interact directly with DNA, binding to specific gene promoter regions in a sequence-specific manner
  • Tissue-specific peptides regulate gene expression in their target organs — e.g., Pancragen (KEDW) in pancreatic tissue, Cortagen (AEDP) in brain cortex, Cardiogen (AEDR) in cardiac tissue
  • A molecular model proposes complementary interactions between short peptides and specific nucleotide sequences in gene promoter regions
  • The mechanism involves chromatin remodeling: peptides can decondense heterochromatin, making previously silenced genes accessible for transcription
  • These effects are proposed to underlie the tissue-specific geroprotective action of Khavinson bioregulator peptides

Study Design

Systematic review of published literature on ultrashort peptide bioregulators and their effects on gene expression. Covers in vitro cell culture studies, animal models, and molecular modeling data from the Khavinson bioregulation research program.

Limitations

  • 95% of studies reviewed originate from the Khavinson group itself — the review is effectively a self-review of their own research program

  • No independent Western laboratory replication is cited
  • Many primary studies were published in Russian-language journals
  • The proposed DNA-binding mechanism has not been validated by independent structural biology groups
  • Evidence level remains preclinical (Level V) despite the systematic review format

Clinical Relevance

This paper provides the most comprehensive overview of the theoretical framework underlying Khavinson short peptide bioregulators. It is useful for understanding the proposed mechanisms but should not be interpreted as validated clinical evidence. Independent replication is needed before clinical conclusions can be drawn.

Methodological Note: This review originates entirely from the Khavinson bioregulation group (Institute of Bioregulation and Gerontology, St. Petersburg). Independent replication by Western laboratories is lacking. All evidence should be interpreted with this single-group limitation in mind.

Related

#research #systematic-review #evidence-level-V #khavinson-bioregulator